Literature DB >> 26209928

Intravenous thrombolysis for acute stroke in a patient on treatment with rivaroxaban.

Lucia Nardetto1, Simone Tonello2, Luigi Zuliani2, Bruno Giometto3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26209928     DOI: 10.1007/s10072-015-2336-5

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  4 in total

1.  Rivaroxaban and apixaban reduce hemorrhagic transformation after thrombolysis by protection of neurovascular unit in rat.

Authors:  Syoichiro Kono; Toru Yamashita; Kentaro Deguchi; Yoshio Omote; Taijun Yunoki; Kota Sato; Tomoko Kurata; Nozomi Hishikawa; Koji Abe
Journal:  Stroke       Date:  2014-07-01       Impact factor: 7.914

Review 2.  Intravenous thrombolysis for stroke in patients taking non-VKA oral anticoagulants: an update.

Authors:  M Cappellari; P Bovi
Journal:  Thromb Haemost       Date:  2015-03-26       Impact factor: 5.249

3.  Intravenous thrombolysis for acute ischemic stroke in a patient receiving rivaroxaban.

Authors:  Anne Landais; Caroline Ginoux
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-10-31       Impact factor: 2.136

4.  Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Edward C Jauch; Jeffrey L Saver; Harold P Adams; Askiel Bruno; J J Buddy Connors; Bart M Demaerschalk; Pooja Khatri; Paul W McMullan; Adnan I Qureshi; Kenneth Rosenfield; Phillip A Scott; Debbie R Summers; David Z Wang; Max Wintermark; Howard Yonas
Journal:  Stroke       Date:  2013-01-31       Impact factor: 7.914

  4 in total
  2 in total

1.  Thrombolysis in an acute ischemic stroke patient with rivaroxaban anticoagulation: A case report.

Authors:  Yen-Tung Chao; Chaur-Jong Hu; Lung Chan
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.889

2.  A case report of parenchymal hematoma after intravenous thrombolysis in a rivaroxaban-treated patient: Is it a true rivaroxaban hemorrhagic complication?

Authors:  Eugenia Rota; Gianluca Bruzzone; Sergio Agosti; Roberto Pastorino; Nicola Morelli
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.